Results 1 to 10 of about 6,359 (137)
Overlapping rheumatoid meningitis with anti‐N‐methyl‐D‐aspartate receptor encephalitis: A case report [PDF]
Clinical Case Reports, 2023 A 66‐year‐old woman in treatment for rheumatoid meningitis was found to be positive for anti‐N‐methyl‐D‐aspartate receptor (NMDAR) antibodies in the cerebrospinal fluid, and intravenous immunoglobulin improved her psychiatric symptoms.
Toshihiro Ide +3 more
doaj +2 more sources
Plasma lipid profiles and homocysteine levels in anti-N-methyl-D-aspartate receptor encephalitis
Frontiers in Neurology, 2023 IntroductionWe aimed to investigate whether lipid profiles and homocysteine levels in patients with anti-N-methyl-D-aspartate receptor encephalitis are related to clinical presentation and prognosis, which may contribute to further research on the ...
Zhi-hao Wang +8 more
doaj +1 more source
Revista Brasileira de Anestesiologia, 2017 Anti-N-methyl-D-aspartate receptor encephalitis is a recently described neurological disorder and an increasingly recognized cause of psychosis, movement disorders and autonomic dysfunction.
Sook Hui Chaw +5 more
doaj +3 more sources
Case Report: Antibodies to the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis
Frontiers in Immunology, 2021 The association between multiple sclerosis and anti-N-Methyl-D-Aspartate receptor encephalitis is limited to merely a few case reports, and the exploration of the pathogenic mechanisms underlying the overlap of these two disease entities is very limited.
Ran Zhou +4 more
doaj +1 more source
Frontiers in Psychiatry, 2023 BackgroundAntibodies against N-methyl-D-aspartate receptors are the most commonly identified cause of autoimmune encephalitis. While predominantly associated with malignancies, cases of anti-N-methyl-D-aspartate receptor autoimmune encephalitis have been
Thomas Hainmueller +4 more
doaj +1 more source
BMC Neurology, 2011 Background Anti-N-methyl-D-aspartate receptor encephalitis is an increasingly common autoimmune disorder mediated by antibodies to certain subunit of the N-methyl-D-aspartate receptor.
Xu Chun-Ling +9 more
doaj +1 more source
Anti‐N‐Methyl‐D‐aspartate receptor encephalitis masquerading as fever of unknown origin
Clinical Case Reports, 2021 Fever of unknown origin (FUO) is a diagnostic challenge. Anti‐N‐methyl‐D‐aspartate receptor encephalitis should be considered in children with FUO and new‐onset neurological symptoms without significant encephalopathy.
Katrina Yi Ching Heng +2 more
doaj +1 more source
Anti N‐Methyl‐D‐Aspartate (NMDA) receptor encephalitis: from psychosis to cognitive impairment
Clinical Case Reports, 2021 In this study, while presenting a clinical case with early psychiatric manifestations, we emphasized the need to pay attention to neurological diagnoses such as Anti N‐Methyl‐D‐Aspartate Receptor (NMDAR) encephalitis at the time of manifestation of these
Zahra Vahabi +4 more
doaj +1 more source
SAGE Open Medical Case Reports, 2020 Anti- N -methyl-D-aspartate receptor encephalitis is a life-threatening medical emergency that can be clinically misperceived as Hashimoto’s encephalopathy.
Mohamed Adil Shah Khoodoruth +2 more
doaj +1 more source
Brain magnetic resonance imaging predictors in anti‐N‐methyl‐D‐aspartate receptor encephalitis
Annals of Clinical and Translational Neurology, 2022 Objective Brain magnetic resonance imaging (MRI) findings in anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis are nonspecific and rarely have obvious associations with clinical characteristics and outcomes.
Ying‐Ying Zhao +8 more
doaj +1 more source